ASX Week 18: small-cap surges meet fading gap rallies

Alvo Minerals (ASX:ALV) led the week with a 76.00% jump after reporting strong copper-zinc drilling at Touro in Brazil. Investors cared because the results pointed to a larger mineralised area, which can lift the value of an early-stage project. Klevo Rewards (ASX:KLV) climbed 44.44% after launching an Australian dollar-backed stablecoin and gaining SWIFT access through Fly Wallet, which matters because it could make its payments business easier to scale. FBR (ASX:FBR) rose 33.33% after landing its first overseas Mantis robot sale and adding new building work, although its low cash balance remains a live risk.

Takeovers put a floor under selected names

Corporate dealmaking was one of the clearest drivers this week. Atlas Arteria (ASX:ALX) gained 10.85% after IFM-backed Diamond Infraco launched a cash bid at A$4.75 per security, with A$5.10 on offer if it reaches a 45% stake. A cash bid matters because it gives holders a clear exit price. Loyal Metals (ASX:LLM) jumped 30.77% after agreeing to a A$79.1 million cash takeover by PT Bumi Resources at A$0.45 a share. Emmerson Resources (ASX:ERM) also stayed in the M&A lane after agreeing to a Pan African Resources deal worth about A$311 million, even though the stock still finished the week down 1.30%. Some of these bid names opened strongly and then lost part of the early lift. That usually means traders quickly priced in the offer and then waited to see if a higher bid would appear, or if conditions attached to the deal could cause delays.

Miners kept chasing cash, scale and quicker production

Resources names again filled most of the news flow. Liontown (ASX:LTR) stood out, rising 17.86% after reporting its strongest quarter since production began, a A$33 million cash increase, and early underground progress ahead of plan. Investors liked that because it showed the mine is now producing cash rather than only consuming it. Cobre (ASX:CBE) added 17.50% after raising A$60 million to buy into a producing Chilean copper asset. Whitehaven Coal (ASX:WHC) gained 8.83% even though quarterly production fell, because coal prices improved and refinancing cut future interest costs. Funding remained a major theme. Minerals 260 (ASX:MI6) secured a A$220 million package from Franco-Nevada, Bannerman Energy (ASX:BMN) locked in US$321.5 million for Etango, and Boab Metals (ASX:BML) finalised a A$236 million debt package for Sorby Hills. In plain terms, these companies now have a clearer way to pay for mine build work. That matters because many projects fail to move forward when the money is not locked in.

Healthcare news moved fast, but not always in one direction

Biotech and medtech names had a mixed week. AdAlta (ASX:1AD) climbed 25.00% after saying its lead cell therapy would be manufactured in Australia following rare complete tumour clearance in mesothelioma patients. Clarity Pharmaceuticals (ASX:CU6) slipped 1.36% despite reporting stronger lesion detection in prostate cancer imaging and closing Phase III recruitment. 4DMedical (ASX:4DX) fell 15.55% even after fresh clearances in Europe and the UK and a large capital raising. Paradigm Biopharma (ASX:PAR) was one of the week’s sharpest fallers, down 28.89%. The company raised cash to keep its Phase 3 knee osteoarthritis study running through an interim result due in the third quarter of 2026. Investors often sell after a raising if they worry more shares have been issued at a low price, or if they think the key result is still too far away.

Tech winners drew buyers, but several rallies faded after the open

Technology moves were strong but uneven. dorsaVi (ASX:DVL) gained 30.00% after pitching its sensor and chip technology into exoskeletons, a market it says could be worth US$2 billion by 2033. FortifAI (ASX:FTI) rose 2.10% on claims its FPGA system can replace large numbers of CPUs and cut running costs, but the stock fell sharply from its reopening level. That tells you early buyers took profits quickly. DXN (ASX:DXN) added 14.29% after posting strong revenue growth and expanding its project pipeline. There were also examples where first reactions did not hold. OpenLearning (ASX:OLL) fell 20.00% despite higher software revenue, and AML3D (ASX:AL3) dropped 17.07% even with a stronger order book and US defence expansion. In simple terms, investors wanted more than a good update. They wanted signs that cash receipts, margins and future orders would turn into steady profit.

What the week said about risk appetite

Across the board, buyers still backed companies that offered one of three things: a takeover price, a funded mine build, or a clear jump in sales or contracts. Traders were less patient with stories that relied on future trials, future permits or future demand without near-term cash support. That helps explain why some stocks opened with big gains but finished well below their session highs. Early excitement was there, but it did not always turn into sustained buying. For next week, the key test is whether these announcements keep pulling in fresh money after the first reaction. If they do not, the market may keep rewarding hard cash, firm bids and funded projects over longer-dated promises.